highlights
-
Financial
MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million
MARIETTA, Ga., April 13, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
BioMimetic Therapeutics Announces Highlights from 2010 Annual Meeting of Stockholders
FRANKLIN, Tenn., Jun 17, 2010 (BUSINESS WIRE) — BioMimetic Therapeutics, Inc. (BMTI 12.64, +0.19, +1.53%)today announced the results of its 2010 Annual Meeting…
Read More »